Safety and Efficacy of Nusinersen and Risdiplam for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Objective: We performed a systematic review and meta-analysis of the efficacy and safety of nusinersen and risdiplam in the treatment of spinal muscular disease (SMA). Methods: We screened the literature published in Pubmed, Web of Science, Embase, and Cochrane before July 2023 to conduct randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Yue, Chi, Yuewei, Gu, Jian, Ma, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605531/
https://www.ncbi.nlm.nih.gov/pubmed/37891788
http://dx.doi.org/10.3390/brainsci13101419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605531/
https://www.ncbi.nlm.nih.gov/pubmed/37891788
http://dx.doi.org/10.3390/brainsci13101419

Ejemplares similares